Temporary: €75 off your second month – for you and every friend
How it works
Medication

Ozempic, Wegovy, Mounjaro and alcohol: can they be taken together?

Can you drink alcohol whilst taking Ozempic, Wegovy, Mounjaro or Saxenda? It is not a prohibited combination, but it may make nausea worse. Read more.

Medically reviewed by Dr. Jaramillo, a doctor at Goodweigh. Last updated on 7 October 2026

Short answer from Dr. Jaramillo

With regard to Ozempic, Wegovy, Mounjaro and alcohol: it is not a prohibited combination, as package leaflets do not list a direct contraindication. However, combining them is strongly discouraged because both alcohol and GLP-1/GIP receptor agonists delay gastric emptying and irritate the gastric mucosa. This significantly exacerbates gastrointestinal side effects like nausea, vomiting, and severe dehydration risk, especially during initial dosing or titration steps. Additionally, alcohol impairs hepatic gluconeogenesis, increasing hypoglycemia risk in patients with diabetes, and poses an independent risk factor for pancreatitis. The clinical recommendation is to avoid alcohol or strictly limit intake to no more than one glass per day.

Dr. Jaramillo, doctor at Goodweigh

Want to find out more? Start your intake here

Ozempic, Wegovy, Mounjaro and alcohol: many users wonder whether they can be taken together. Some find they’re less keen on a drink, whilst others feel nauseous more quickly. In this blog, you’ll find out what is known, what symptoms you might notice and what research shows about cutting down on alcohol. You’ll also find out when it’s best to avoid alcohol altogether.

We will be discussing semaglutide (found in Ozempic, Wegovy, Rybelsus and the Wegovy tablet), tirzepatide (found in Mounjaro) and liraglutide (found in Saxenda).

Can you drink alcohol whilst taking Ozempic, Wegovy, Mounjaro, Saxenda or Rybelsus?

Alcohol is not prohibited with Wegovy, Ozempic, Mounjaro, Saxenda and Rybelsus. It can still have consequences, though.

Our doctors recommend avoiding alcohol as much as possible, as it can make nausea and vomiting worse. It can also increase the risk of severe dehydration, and the risk of hypoglycemia in patients with diabetes. The NHG Standard on Obesity advises against drinking alcohol, or at least not more than one glass a day. Alcohol is also high in calories, which doesn’t help if you’re trying to lose weight. Find out more about what to eat whilst taking GLP-1 medication.

What do you notice if you drink whilst undergoing GLP-1 treatment?

The most common side effect is an upset stomach. These medicines slow down the emptying of your stomach, so you don’t feel hungry as quickly. Nausea, vomiting, diarrhoea and constipation occur in more than 1 in 10 users of semaglutide, liraglutide and tirzepatide. Adding alcohol to an already sensitive stomach can significantly exacerbate these symptoms. Both alcohol and GLP-1 medications irritate the gastric mucosa and delay gastric emptying, increasing the risk of severe nausea, vomiting, and acid reflux.

In studies of Wegovy, more than 4 in 10 users experienced nausea. With Mounjaro, this was around a quarter to a third, and more common during dose escalation, according to the patient information leaflet. Would you like to know what you can do to manage these symptoms? Then read about nausea associated with GLP-1 medication and the side effects of GLP-1 medication. It is best to avoid alcohol during the first few weeks of treatment and when your dose is increased.

Does it make you get drunk more quickly? We don’t know. The patient information leaflet for Mounjaro states that slower gastric emptying may affect how quickly other tablets or drinks containing medicines are absorbed. As far as we could find, no studies have been carried out in humans to determine whether this also applies to alcohol. Reports from users about getting drunk quickly or suffering from severe hangovers are anecdotal and do not constitute a proven effect.

Can GLP-1 medication help you drink less?

It is possible, but there are still few studies, and they focus primarily on individuals with diagnosed alcohol use disorder (AUD), rather than casual drinkers. In a study published in JAMA Psychiatry, 48 people were randomly assigned to receive either a low dose of semaglutide or a placebo. They drank less during a laboratory trial. At home, they did not drink on fewer days, but they did consume fewer glasses on the days they did drink.

A Danish study published in The Lancet followed 108 people with an alcohol problem and obesity who were seeking help. When taking semaglutide, they had fewer days of heavy drinking, although they experienced mild to moderate gastrointestinal symptoms more frequently. A Danish registry study of people with diabetes showed a possible temporary protective effect in the first few months. As participants in this study were not randomly assigned, the evidence is weaker.

A systematic review of all studies to date comes to the same conclusion: the findings look promising, but further research is needed. We found no controlled trials on Mounjaro (tirzepatide) or Saxenda (liraglutide) in relation to alcohol problems. None of these medicines (Wegovy, Ozempic, Mounjaro, Saxenda, or Rybelsus) is approved for the treatment of alcohol problems. If you are struggling with alcohol consumption, please consult your GP about treatments that have been proven to work.

What happens if you vomit after drinking alcohol?

You lose fluid, and this is a point to bear in mind with these medicines. The information leaflet for Wegovy states that you must drink plenty of fluids to prevent dehydration. Combining alcohol with these medications exacerbates fluid loss in two ways: alcohol acts as a direct diuretic, while GLP-1-induced nausea, vomiting, or diarrhoea further depletes volume. Severe dehydration can impair renal perfusion, leading to a sudden deterioration in kidney function or acute kidney injury (AKI).

You should therefore drink water if you have been vomiting. If you continue to vomit, or if you have severe and persistent pain in your stomach area, contact a doctor straight away. Have you noticed any side effects? You can report them to Lareb.

When is it best to avoid alcohol?

You should strictly avoid alcohol, or discuss it with your doctor first, in three situations. The first is a history of pancreatitis. Both heavy alcohol use and GLP-1/GIP medications (such as Wegovy, Ozempic, Mounjaro, Saxenda, and Rybelsus) are associated with acute pancreatitis. Combining alcohol with these treatments can elevate the risk of pancreatic inflammation.

The second scenario is type 2 diabetes treated with insulin or a specific type of blood sugar-lowering tablet. In this case, your blood sugar levels may become too low, for example when taking semaglutide. This combination requires consultation with your treating doctor. Ozempic is authorised for type 2 diabetes. Our doctors do not combine GLP-1 medication with these medicines.

The third is poor liver function. Wegovy is not recommended in cases of severely impaired liver function. Are you pregnant or planning to become pregnant? If so, discuss with your doctor whether you can take these medicines and drink alcohol.

Does it vary depending on the medication: Ozempic, Wegovy, Rybelsus, Mounjaro and Saxenda?

Not when it comes to alcohol: the advice is the same for all five, and the points to note are very similar. The main differences lie in the active ingredient and in who uses the medicine. Ozempic and Rybelsus are authorised for type 2 diabetes. Wegovy and Saxenda are intended for obesity, whilst Mounjaro is intended for both conditions.

The table summarises the information contained in the patient information leaflets. Want to know more about the differences? See the comparison of Ozempic, Wegovy, Mounjaro and Saxenda.

‍

Medicine (active ingredient) Take care when using insulin or certain diabetes tablets Previous pancreatitis
Ozempic (semaglutide) Yes (hypoglycemia risk) Caution is advised
Wegovy (semaglutide) Yes (hypoglycemia risk) Caution is advised
Rybelsus (semaglutide) Yes (hypoglycemia risk) Reported with GLP-1 agents
Mounjaro (tirzepatide) Yes (hypoglycemia risk) Caution is advised
Saxenda (liraglutide) Yes (hypoglycemia risk) Reported with GLP-1 agents

‍

Oral semaglutide (Rybelsus and the Wegovy tablet) has its own rule: it must be taken on an empty stomach with a maximum of 120 ml of plain water. You must wait at least 30 minutes before eating, drinking (including alcohol), or taking other medications to ensure proper absorption. An aperitif immediately after taking your tablet is therefore strictly not advisable.

We have no reliable information regarding alcohol consumption with newer medicines such as retatrutide or orforglipron, so this advice applies only to the medicines mentioned in this blog.

Can you drink alcohol whilst taking the Wegovy tablet?

The Wegovy pill contains the same active ingredient as the Wegovy injection: semaglutide. The same advice on alcohol therefore applies as for the injection: avoid alcohol as much as possible, because it can worsen nausea, vomiting and dehydration. If you do drink, have no more than one glass a day.

With a tablet, you also need to consider when to take it. With Rybelsus, which is also a tablet containing semaglutide, you should take the tablet on an empty stomach and then wait at least 30 minutes before eating or drinking. So do not drink alcohol immediately after taking the Wegovy tablet. For the exact guidelines, follow the patient information leaflet for your tablet and your doctor’s advice. You can read more in Wegovy tablet: oral semaglutide.

Alcohol and GLP-1 medication: make an informed choice

There is no strict ban on alcohol whilst taking these medicines, but the medical advice is to avoid it or drink as little as possible (limiting intake to no more than one glass a day per the NHG Obesity Guideline). Take care of your stomach, stay well-hydrated with water, and take extra precautions if you have diabetes, a history of pancreatitis, or liver problems. Goodweigh will discuss these guidelines during your intake and coaching sessions to ensure a safe treatment tailored to your individual situation.

Frequently Asked Questions

Can I have a glass of wine whilst taking Ozempic or Wegovy?

It is not prohibited, but our doctors recommend avoiding alcohol as much as possible, as it can make nausea and vomiting worse. The NHG Obesity Standard advises against alcohol, or at least no more than one glass a day.

Do I get drunk more quickly on Mounjaro or Ozempic?

As far as we could find, this has not been investigated. With Mounjaro, slower gastric emptying may alter the absorption of other oral medicines. Whether this also applies to alcohol is not known. Users’ experiences do not constitute evidence.

Do Mounjaro or Ozempic help with alcohol addiction?

That has not been proven. Small studies have been carried out on semaglutide (in Ozempic and Wegovy) in people with an alcohol problem, showing a slight reduction in the number of days of heavy drinking. We found no controlled study on Mounjaro, and none of these medicines is approved as a treatment for alcohol dependence.

What should I do if I vomit after drinking alcohol?

Drink water to prevent dehydration and eat something light if you can. If you keep vomiting, or if you have severe pain in your stomach area that won’t go away, contact a doctor straight away.

Can I drink alcohol whilst taking Saxenda or Rybelsus?

Yes, but here too the advice is to drink as little as possible. With Rybelsus, you should wait at least 30 minutes after taking your tablet before eating or drinking, including alcohol.

Bronnen
  1. Hendershot, C. S., Bremmer, M. P., Paladino, M. B., et al. (2025). Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry, 82(4), 395-405. https://pubmed.ncbi.nlm.nih.gov/39937469/
  2. Klausen, M. K., Justesen, S. K., Pedersen, J. N., et al. (2026). Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. The Lancet, 407(10540), 1687-1698. https://pubmed.ncbi.nlm.nih.gov/42070571/
  3. Wium-Andersen, I. K., Wium-Andersen, M. K., Fink-Jensen, A., et al. (2022). Use of GLP-1 receptor agonists and subsequent risk of alcohol-related events. A nationwide register-based cohort and self-controlled case series study. Basic & Clinical Pharmacology & Toxicology, 131(5), 372-379. https://pubmed.ncbi.nlm.nih.gov/35968738/
  4. Patel, S., et al. (2025). GLP-1 receptor agonists and alcohol use disorder: a systematic review. Alcohol and Alcoholism. https://pubmed.ncbi.nlm.nih.gov/41273789/
  5. Nederlands Huisartsen Genootschap. (2025). NHG-Standaard Obesitas (M95), versie 2.1. https://richtlijnen.nhg.org/standaarden/obesitas
  6. Farmacotherapeutisch Kompas. Semaglutide. https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/s/semaglutide
  7. Farmacotherapeutisch Kompas. Liraglutide. https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/l/liraglutide
  8. European Medicines Agency. Wegovy: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/wegovy-epar-product-information_nl.pdf
  9. European Medicines Agency. Ozempic: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/ozempic-epar-product-information_nl.pdf
  10. European Medicines Agency. Mounjaro: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/mounjaro-epar-product-information_nl.pdf
  11. European Medicines Agency. Saxenda: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/saxenda-epar-product-information_nl.pdf
  12. European Medicines Agency. Rybelsus: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/rybelsus-epar-product-information_nl.pdf